It’s important to note that while side effects can occur with SABR, they are typically mild and temporary, with most patients experiencing minimal disruption to their daily activities. The frequency and severity of side effects can vary depending on factors such as the size and location of the tumour, the dose of radiation delivered, and individual patient characteristics.
According to research studies and clinical trials, the incidence of severe (grade 3 or higher) side effects with SABR for lung cancer is relatively low, ranging from 1% to 10%. Common mild to moderate side effects, such as fatigue and chest discomfort, are more frequently reported but are generally well-tolerated and manageable with supportive care measures.
Before you start treatment, you’ll be given a number that gives you access to support and care 24/7 if you were to be concerned about your symptoms.